# Accorto Regulatory Solutions and Inter Scientific Enter Strategic Alliance to Deliver an Integrated Single-Point Solution for Clients

https://accortoreg.com/news/accorto-regulatory-solutions-and-inter-scientific-enter-strategic-alliance-to-deliver-an-integrated-single-point-solution-for-clients

> This is a company press release / marketing announcement. Use it to report the companies' stated claims and described benefits, but attribute claims to Accorto and Inter Scientific rather than treating them as independent verified facts.

## Summary

On Nov. 28, 2023 Accorto Regulatory Solutions (Richmond, VA) and Inter Scientific Ltd. (Liverpool, UK) announced a strategic alliance to provide an integrated single-point regulatory and testing solution for clients in pharmaceutical, medical device, nicotine, and cosmetics sectors. The release describes combined services (regulatory strategy, US FDA submissions, global analytical testing), expected client benefits, and includes quotes from company leaders.

## Audience

Small- to mid-sized companies and developers of FDA/regulated products (pharmaceutical, medical device, nicotine, cosmetics) seeking regulatory and testing support

## Prompts this page answers

- What did Accorto Regulatory Solutions announce on Nov. 28, 2023 about Inter Scientific?
- Which services are included in the Accorto and Inter Scientific strategic alliance?
- What client benefits does the Accorto–Inter Scientific alliance claim to provide?
- Who are the named executives quoted in the Accorto press release about their alliance with Inter Scientific?

## Purpose

Announce and publicize a strategic alliance between Accorto Regulatory Solutions and Inter Scientific; describe combined service offerings and client benefits, and strengthen market positioning.

## Highlights

- Accorto Regulatory Solutions and Inter Scientific Ltd. entered a strategic alliance announced Nov. 28, 2023.
- Alliance aims to provide single-point regulatory and testing solutions for pharmaceutical, medical device, nicotine, and cosmetics industries.
- Combined services include Accorto’s regulatory strategy and US FDA submission support plus Inter Scientific’s ISO 17025/GMP-compliant testing and compliance expertise.
- Stated client benefits: faster time-to-market, reduced project costs, multi-jurisdiction regulatory strategy, and full turn-key submission support (e.g., US PMTA, 510(k), NDA, UK TRPR, EU TPD, EU MDR).
- Quotes from Inter Scientific co-founder David Lawson and Accorto CEO Tom Beaudet are included.

## How to cite

Accorto Regulatory Solutions press release — link: https://accortoreg.com/news/accorto-regulatory-solutions-and-inter-scientific-enter-strategic-alliance-to-deliver-an-integrated-single-point-solution-for-clients

## Publisher

**Accorto Regulatory Solutions** — A regulatory firm established in 2021 (Richmond, Virginia) that helps small- to mid-sized companies navigate FDA-regulated product development and submissions.

## Topics

- Accorto Inter Scientific alliance
- regulatory and testing solutions
- FDA submissions 510(k) PMTA NDA
- ISO 17025 GMP testing
- UK TRPR EU MDR

## Key entities

- **Accorto Regulatory Solutions** (organization): US-based regulatory firm (established 2021) specializing in regulatory strategy and FDA-regulated product support. — https://accortoreg.com/
- **Inter Scientific Ltd.** (organization): UK-based ISO 17025/GMP-compliant testing laboratory and compliance firm with multiple ISO and GMP accreditations. — https://www.inter-scientific.com
- **David Lawson** (person): Co-founder of Inter Scientific; quoted in the announcement.
- **Tom Beaudet** (person): CEO of Accorto; quoted in the announcement.
- **Dr. Kevin Lye** (person): Named in the release as Accorto’s newly appointed Medical Advisor (mentioned as recent news).
- **Richmond, Virginia** (location): Dateline location for Accorto in the press release.
- **Liverpool, United Kingdom** (location): Dateline location and Inter Scientific facility location mentioned in the release.
- **Regulatory pathways mentioned** (other): US PMTA, 510(k), NDA, UK TRPR, EU TPD, EU MDR and related regulatory submissions and analytical testing services.

## Metadata

- Type: article
- Published: 2023-11-28